Target intelligence / Profile preview

SLCO5A1 antisense RNA 1 (SLCO5A1-AS1)

Target
SLCO5A1-AS1
Molecular classification
Long non-coding RNA, antisense RNA
01

Overview

SLCO5A1 antisense RNA 1 (SLCO5A1-AS1) is a long non-coding RNA gene mapped to chromosome 8 that is transcribed antisense to the SLCO5A1 gene. It is annotated in major gene databases and reference genomes, but as of September 2025, there is no published research establishing its biological function, involvement in disease processes, or utility as a therapeutic target. Unlike some other antisense or lncRNAs, its regulatory significance remains uncharacterized, with no documented impact on cell signaling, disease, or drug response[4]. Additional notes: - There is no evidence of misspelling or misidentification: the entry correctly refers to a bona fide annotated human gene/transcript[4]. - No aliases or alternative names have been documented beyond the primary designation in major databases[4]. - Data and literature currently do not support classifying SLCO5A1-AS1 as a drug target, biomarker, or disease mechanism. - This distinguishes SLCO5A1-AS1 from similar antisense RNAs that play established roles in regulation or disease (such as BBOX1-AS1[2]). - SLCO5A1 (not the antisense transcript) encodes an organic anion transporter with emerging evidence in cancer biology and cell differentiation[1][5], but SLCO5A1-AS1's role is not defined.

Other names
SLCO5A1-AS1

Beyond the preview

Go deeper on SLCO5A1 antisense RNA 1 (SLCO5A1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLCO5A1 antisense RNA 1 (SLCO5A1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call